Statistics by Country for Ovarian Cancer
|
About these extrapolations of prevalence and incidence statistics for Ovarian Cancer:
These statistics are calculated extrapolations of various prevalence or incidence rates
against the populations of a particular country or region.
The statistics used for prevalence/incidence of Ovarian Cancer are typically based on US, UK, Canadian or Australian statistics.
This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences
across the various countries and regions for which the extrapolated Ovarian Cancer statistics below refer to.
As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication)
as to the actual prevalence or incidence of Ovarian Cancer in that region.
About prevalence and incidence statistics in general for Ovarian Cancer: The word 'prevalence' of Ovarian Cancer usually means the estimated population of people who are managing Ovarian Cancer at any given time (i.e. people with Ovarian Cancer). The term 'incidence' of Ovarian Cancer means the annual diagnosis rate, or the number of new cases of Ovarian Cancer diagnosed each year (i.e. getting Ovarian Cancer). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics. |
Incidence (annual) of Ovarian Cancer: 23,300 annual cases in USA (SEER 2002 estimate); about 1 in 57 women in the United States (NCI)
Incidence Rate for Ovarian Cancer: approx 1 in 11,673 or 0.01% or 23,300 people in USA [about data]
Extrapolation of Incidence Rate for Ovarian Cancer to Countries and Regions: The following table attempts to extrapolate the above incidence rate for Ovarian Cancer to the populations of various countries and regions. As discussed above, these incidence extrapolations for Ovarian Cancer are only estimates and may have limited relevance to the actual incidence of Ovarian Cancer in any region:
| Country/Region | Extrapolated Incidence | Population Estimated Used |
| Ovarian Cancer in North America (Extrapolated Statistics) | ||
| USA | 25,155 | 293,655,4051 |
| Canada | 2,784 | 32,507,8742 |
| Ovarian Cancer in Europe (Extrapolated Statistics) | ||
| Austria | 700 | 8,174,7622 |
| Belgium | 886 | 10,348,2762 |
| Britain (United Kingdom) | 5,162 | 60,270,708 for UK2 |
| Czech Republic | 106 | 1,0246,1782 |
| Denmark | 463 | 5,413,3922 |
| Finland | 446 | 5,214,5122 |
| France | 5,176 | 60,424,2132 |
| Greece | 912 | 10,647,5292 |
| Germany | 7,060 | 82,424,6092 |
| Iceland | 25 | 293,9662 |
| Hungary | 859 | 10,032,3752 |
| Liechtenstein | 2 | 33,4362 |
| Ireland | 340 | 3,969,5582 |
| Italy | 4,973 | 58,057,4772 |
| Luxembourg | 39 | 462,6902 |
| Monaco | 2 | 32,2702 |
| Netherlands (Holland) | 1,397 | 16,318,1992 |
| Poland | 3,308 | 38,626,3492 |
| Portugal | 901 | 10,524,1452 |
| Spain | 3,450 | 40,280,7802 |
| Sweden | 769 | 8,986,4002 |
| Switzerland | 638 | 7,450,8672 |
| United Kingdom | 5,162 | 60,270,7082 |
| Wales | 249 | 2,918,0002 |
| Ovarian Cancer in the Balkans (Extrapolated Statistics) | ||
| Albania | 303 | 3,544,8082 |
| Bosnia and Herzegovina | 34 | 407,6082 |
| Croatia | 385 | 4,496,8692 |
| Macedonia | 174 | 2,040,0852 |
| Serbia and Montenegro | 927 | 10,825,9002 |
| Ovarian Cancer in Asia (Extrapolated Statistics) | ||
| Bangladesh | 12,107 | 141,340,4762 |
| Bhutan | 187 | 2,185,5692 |
| China | 111,261 | 1,298,847,6242 |
| East Timor | 87 | 1,019,2522 |
| Hong Kong s.a.r. | 587 | 6,855,1252 |
| India | 91,235 | 1,065,070,6072 |
| Indonesia | 20,426 | 238,452,9522 |
| Japan | 10,907 | 127,333,0022 |
| Laos | 519 | 6,068,1172 |
| Macau s.a.r. | 38 | 445,2862 |
| Malaysia | 2,014 | 23,522,4822 |
| Mongolia | 235 | 2,751,3142 |
| Philippines | 7,387 | 86,241,6972 |
| Papua New Guinea | 464 | 5,420,2802 |
| Vietnam | 7,081 | 82,662,8002 |
| Singapore | 372 | 4,353,8932 |
| Pakistan | 13,637 | 159,196,3362 |
| North Korea | 1,944 | 22,697,5532 |
| South Korea | 4,131 | 48,233,7602 |
| Sri Lanka | 1,705 | 19,905,1652 |
| Taiwan | 1,948 | 22,749,8382 |
| Thailand | 5,556 | 64,865,5232 |
| Ovarian Cancer in Eastern Europe (Extrapolated Statistics) | ||
| Azerbaijan | 674 | 7,868,3852 |
| Belarus | 883 | 10,310,5202 |
| Bulgaria | 644 | 7,517,9732 |
| Estonia | 114 | 1,341,6642 |
| Georgia | 402 | 4,693,8922 |
| Kazakhstan | 1,297 | 15,143,7042 |
| Latvia | 197 | 2,306,3062 |
| Lithuania | 309 | 3,607,8992 |
| Romania | 1,915 | 22,355,5512 |
| Russia | 12,333 | 143,974,0592 |
| Slovakia | 464 | 5,423,5672 |
| Slovenia | 172 | 2,011,473 2 |
| Tajikistan | 600 | 7,011,556 2 |
| Ukraine | 4,088 | 47,732,0792 |
| Uzbekistan | 2,262 | 26,410,4162 |
| Ovarian Cancer in Australasia and Southern Pacific (Extrapolated Statistics) | ||
| Australia | 1,705 | 19,913,1442 |
| New Zealand | 342 | 3,993,8172 |
| Ovarian Cancer in the Middle East (Extrapolated Statistics) | ||
| Afghanistan | 2,442 | 28,513,6772 |
| Egypt | 6,520 | 76,117,4212 |
| Gaza strip | 113 | 1,324,9912 |
| Iran | 5,782 | 67,503,2052 |
| Iraq | 2,173 | 25,374,6912 |
| Israel | 531 | 6,199,0082 |
| Jordan | 480 | 5,611,2022 |
| Kuwait | 193 | 2,257,5492 |
| Lebanon | 323 | 3,777,2182 |
| Libya | 482 | 5,631,5852 |
| Saudi Arabia | 2,209 | 25,795,9382 |
| Syria | 1,543 | 18,016,8742 |
| Turkey | 5,901 | 68,893,9182 |
| United Arab Emirates | 216 | 2,523,9152 |
| West Bank | 197 | 2,311,2042 |
| Yemen | 1,715 | 20,024,8672 |
| Ovarian Cancer in South America (Extrapolated Statistics) | ||
| Belize | 23 | 272,9452 |
| Brazil | 15,770 | 184,101,1092 |
| Chile | 1,355 | 15,823,9572 |
| Colombia | 3,624 | 42,310,7752 |
| Guatemala | 1,223 | 14,280,5962 |
| Mexico | 8,991 | 104,959,5942 |
| Nicaragua | 459 | 5,359,7592 |
| Paraguay | 530 | 6,191,3682 |
| Peru | 2,359 | 27,544,3052 |
| Puerto Rico | 333 | 3,897,9602 |
| Venezuela | 2,143 | 25,017,3872 |
| Ovarian Cancer in Africa (Extrapolated Statistics) | ||
| Angola | 940 | 10,978,5522 |
| Botswana | 140 | 1,639,2312 |
| Central African Republic | 320 | 3,742,4822 |
| Chad | 817 | 9,538,5442 |
| Congo Brazzaville | 256 | 2,998,0402 |
| Congo kinshasa | 4,995 | 58,317,0302 |
| Ethiopia | 6,110 | 71,336,5712 |
| Ghana | 1,778 | 20,757,0322 |
| Kenya | 2,825 | 32,982,1092 |
| Liberia | 290 | 3,390,6352 |
| Niger | 973 | 11,360,5382 |
| Nigeria | 1,520 | 12,5750,3562 |
| Rwanda | 705 | 8,238,6732 |
| Senegal | 929 | 10,852,1472 |
| Sierra leone | 504 | 5,883,8892 |
| Somalia | 711 | 8,304,6012 |
| Sudan | 3,353 | 39,148,1622 |
| South Africa | 3,807 | 44,448,4702 |
| Swaziland | 100 | 1,169,2412 |
| Tanzania | 3,089 | 36,070,7992 |
| Uganda | 2,260 | 26,390,2582 |
| Zambia | 944 | 11,025,6902 |
| Zimbabwe | 314 | 1,2671,8602 |
Lifetime risk for Ovarian Cancer: 1.4% lifetime risk; 1 in 108 women will develop ovarian cancer during their lifetime in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
Footnotes:
1. US Census Bureau, Population Estimates, 2004
2. US Census Bureau, International Data Base, 2004
Last revision: June 5, 2003
Medical Tools & Articles:
Next articles:
Medical Articles: